By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Sorry Lipitor, You’re No Match for Generics
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Sorry Lipitor, You’re No Match for Generics
BusinessNews

Sorry Lipitor, You’re No Match for Generics

DavidEWilliams
DavidEWilliams
Share
3 Min Read
SHARE

Pfizer received a flurry of attention toward the end of November as its blockbuster statin Lipitor came to the end of its patent protection. Many media outlets were impressed with Pfizer’s aggressive, multi-pronged plan to compete with generic versions of the drug through special deals with pharmacy benefit managers, price inducements to consumers and heavy advertising.

Pfizer received a flurry of attention toward the end of November as its blockbuster statin Lipitor came to the end of its patent protection. Many media outlets were impressed with Pfizer’s aggressive, multi-pronged plan to compete with generic versions of the drug through special deals with pharmacy benefit managers, price inducements to consumers and heavy advertising. For example, here’s what the New York Times had to say in Facing Generic Lipitor Rivals, Pfizer Battles to Protect Its Cash Cow:

The company’s aggressive strategy may offer lessons for drug makers facing similar losses of patent protection for other blockbuster drugs over the next few years, and may chart a new path for shifts between the big pharmaceutical companies and generic rivals…

With Pfizer’s plans to try to maintain brand loyalty for the next six months becoming public, industry analysts have raised the company’s earnings outlook by 2 to 4 percent, and now estimate that it could retain 40 percent of the market through next year.

More Read

A Look at Oncology Medication Management
Generation Alzheimer’s – New Report New Facts – Funding Needed
How To Prepare For Medical School And Maximize Results
Medical Identity Theft: The Low-Hanging Fruit for Thieves
Study: Emergency Dept. Performance Measure Quite Stable among Safety Net, Other Hospitals

Instead it looks like Lipitor is behaving just about like any other drug going generic. From the Washington Post:

Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world’s top-selling drug got its first U.S. generic competition, new data show.

That’s despite a very aggressive effort by Lipitor maker Pfizer Inc. to keep patients on its pill, which generated peak sales of $13 billion a year, through patient subsidies and big rebates to insurers.

Big pharma can only win long term by develop innovative new compounds that generate clinical and economic value. They can absolutely forget about making money in the face of generic competition.


TAGGED:LipitorPfizerpharmaceuticals
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025
Traumatic Brain Injuries
Understanding Traumatic Brain Injuries: What Families Need to Know
Policy & Law
October 10, 2025
Remote Monitoring touchpoints
Remote Monitoring Touchpoints Patients Will Actually Follow
Technology
October 9, 2025
dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025

You Might also Like

BusinessNews

Doctors 2.0 – Second Post

June 9, 2013

Concierge Medicine Will be Driven by Looming Doctor Shortage

September 13, 2012

3 Quick Ways to Boost Your Hospital’s Social Media Strategy

March 20, 2015

Healthcare Reputation Management in a Web 3.0 World

March 16, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?